Then we connect that foundation to R² (coefficient of determination) — and This Is Why it’s critical for understanding how much variability one variable explains in another. Through clinical context and practical examples, you’ll see how these concepts apply to real-world decision-making, not just test questions.

If you’ve ever confused association with causation or struggled to interpret R values, this episode will help you connect the “why” behind the numbers.

Topics Covered:

- Correlation coefficient (r) definition

- Strength vs direction of relationships

- Why correlation does NOT equal causation

- Confounding variables explained

- Interpreting R values clinically

- Coefficient of determination (R²)

- Variability explained between variables

- Clinical example: calories and weight

- Relationship vs prediction in statistics

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/correlation-coefficient-vs-r-squared

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#correlation coefficient #R squared #biostatistics explained #coefficient of determination #Dr Busti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

After the initial management of acute MI, the real question becomes: what else improves survival and prevents long-term damage? The GISSI-3 trial tackled this directly, evaluating early ACE inhibitor therapy and routine nitrate use in a large, real-world population.

Dr. Busti breaks down how lisinopril provided a modest but meaningful mortality benefit—and why that matters more than it seems. More importantly, we explore the why behind early RAAS blockade, how it impacts ventricular remodeling, and which patients benefit the most.

This is not about memorizing treatment steps—it’s about understanding how small, evidence-based decisions compound to improve patient outcomes.

Topics Covered:

- Why the GISSI-3 trial was needed

- Trial design and 2x2 factorial structure

- Early ACE inhibitor therapy after MI

- Mortality and combined endpoint outcomes

- Absolute vs relative risk reduction

- Why nitrates did not improve survival

- Mechanism of RAAS blockade and remodeling

- High-risk subgroups (diabetes, anterior MI, LV dysfunction)

- Limitations of GISSI-3 in modern practice

- Applying early ACE inhibitors clinically

👉 Download the full clinical trial handout with a free membership at: https://www.thisiswhy.health/topics/gissi-3-trial-ace-inhibitors-after-mi-landmark-clinical

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

#GISSI3Trial #ACEinhibitorsMI #postMIcare #ventricularremodeling #Dr Bust

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#GISSI3Trial #ACEinhibitorsMI #postMIcare #ventricularremodeling #DrBust

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content. 

In this This Is Why lecture, Dr. Busti walks through the core measures of central tendency and variability and shows how they relate to data type, study design, and proper interpretation.

This is where many learners make mistakes—especially when interpreting skewed data, choosing between mean vs median, or understanding the difference between standard deviation and standard error.

This episode builds directly on the Biostatistics Framework and helps you recognize when data may be misleading or incorrectly presented.

Topics Covered:

- Mean, median, and mode explained

- Measures of variability and dispersion

- Standard deviation vs standard error of the mean

- How data type determines statistical description

- Nominal, ordinal, and continuous data (applied concepts)

- Skewed data (positive vs negative skew)

- Relationship between mean, median, and mode

- Interquartile range (IQR) explained

- Identifying outliers in clinical data

- 95% confidence interval (conceptual understanding)

The goal = make medical education easy and clinically relevant.

👉 Looking for Q-Banks to practice applying the concepts? We have Q-Banks at: https://www.highyieldmedreviews.com/ebm-biostatistics-literature-review-medicine

📚 Need a structured curriculum for your university or residency program? We would love to discuss how we can partner with you: https://www.highyieldmedreviews.com/residency-training-programs-services-and-package

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#meanmedianmode #standarddeviation #standarderror #biostatisticsbasics #DrBusti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture on This Is Why, Dr. Busti will explain what statistical power really means, how it relates to beta and Type II error, and why sample size plays a critical role in identifying true differences in clinical studies. He walks through the conceptual meaning of power—not just the formula—and shows how clinicians and researchers should interpret study results when no difference is found.

This lecture is part of the This Is Why (TIW) evidence-based medicine series, a connected playlist designed to build a deeper understanding of biostatistics and clinical reasoning. Be sure to explore the full series to strengthen your ability to critically evaluate medical literature.

Topics Covered:

- Definition of statistical power (1 − beta)

- Type II error and its clinical meaning

- Relationship between power and beta

- Why power reflects the probability of detecting a true difference

- Impact of sample size on study conclusions

- Factors influencing power analysis

- One-sided vs two-sided hypothesis testing

- Study design considerations (crossover vs randomized trials)

- Interpreting studies with no statistically significant difference

- Clinical implications of underpowered studies

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#PowerAnalysis #TypeIIError #Biostatistics #EvidenceBasedMedicine #Dr Busti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture on This Is Why, Dr. Busti will explain what alpha represents, how it is determined, and how clinicians should interpret it when evaluating medical literature. This session clarifies the relationship between alpha, Type I error, hypothesis testing, and study power, helping learners connect statistical theory to real clinical decision-making.

This lecture is part of the broader This Is Why evidence-based medicine series, where each concept builds on previous topics to strengthen your ability to critically evaluate research.

Be sure to explore the full playlist to connect concepts like hypothesis testing, power analysis, and statistical errors.

Topics Covered:

- Definition of alpha in clinical research

- Alpha as probability of Type I error

- Interpreting alpha in published studies

- One-tailed vs two-tailed hypothesis testing

- Relationship between alpha and study power

- Type I error vs correct decision-making

- Clinical implications of statistical error

- Role of alpha in evidence-based medicine

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#alpha value #type I error #biostatistics #clinical research #Dr Busti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture on This Is Why, Dr. Busti brings the full biostatistics framework of the Statistical Analysis Plan (SAP) together—connecting data type, distribution, and study groups to the correct statistical analysis.

Understanding when to use parametric vs. nonparametric tests is critical for interpreting clinical research and avoiding common mistakes when evaluating data in evidence-based medicine (EBM).

This lecture reinforces how normal vs skewed data, outliers, and data classification influence statistical decision-making.

Topics Covered:

- Parametric vs nonparametric statistical tests

- Normal distribution vs non-normal data

- Role of data type in statistical analysis

- Impact of outliers and skewed data

- Nominal, ordinal, and continuous data review

- How distribution affects test selection

- Connecting data, groups, and statistical tests

- Interpreting how data is presented in research

- Clinical implications of incorrect statistical analysis

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/parametric-vs-nonparametric-statistical-tests-biostatistics

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#parametricvsnonparametric #biostatistics #statisticaltests #EBM #DrBusti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this This Is Why lecture, Dr. Busti breaks down one of the most important steps in biostatistics—identifying the type of study groups and how that directly impacts statistical test selection.

Understanding whether groups are independent or related is essential for interpreting clinical trials and avoiding common mistakes when reading research.

This lecture builds on prior topics and moves you closer to confidently choosing the correct statistical analysis.

Topics Covered:

- Independent vs paired (related) study groups

- How study design determines statistical testing

- Randomized controlled trials and independent groups

- Crossover and pre-post study designs

- Matched and paired data concepts

- Number of groups and its impact on analysis

- Role of study groups in statistical decision-making

- Connecting study design to hypothesis testing framework

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/independent-vs-paired-study-groups-biostatistics

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#independentvspaired #studygroups #biostatistics #clinicalresearch #Dr Busti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this episode, Dr. Busti breaks down how to think through a medication safety question step by step, identify common board traps, and connect the pharmacology to real patient care.

Topics Covered:

- Parkinson disease medication management

- Medication discontinuation safety

- Adverse effects and treatment adjustment

- Board-style pharmacology reasoning

- How to analyze discontinuation questions

- Common distractors in medication safety questions

- Clinical thinking for neurologic drug therapy

- Patient counseling during medication changes

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#ParkinsonDisease #MedicationSafety #Pharmacology #ClinicalReasoning #DrBusti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture on This Is Why, Dr. Busti walks through one of the most critical steps in biostatistics: correctly identifying the type of data based on the study question.

This is where many learners make mistakes—especially when distinguishing between ordinal vs continuous data, recognizing skewed data, or understanding when to use parametric vs non-parametric analysis.

This lecture connects directly to prior topics on study groups and variability, bringing you closer to confidently choosing the correct statistical test.

Topics Covered:

- Nominal, ordinal, and continuous data explained

- How the study question determines data type

- Parametric vs non-parametric data concepts

- Normal distribution vs skewed data

- Relationship between mean, median, and mode

- When continuous data should not be treated as parametric

- Impact of outliers on data interpretation

- Interpreting data for correct statistical test selection

- How endpoints can change data classification (e.g., yes/no vs average)

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-of-data-nominal-ordinal-continuous-biostatistics

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#typesofdata #nominalordinalcontinuous #biostatistics #clinicalresearch #Dr Busti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this This Is Why (TIW) lecture, Dr. Busti introduces the biostatistics decision-making framework that connects hypothesis, study design, and data type to the correct statistical analysis.

This is not a memorization lecture—it’s about understanding the structure behind statistical choices so you can evaluate research correctly as a clinician or researcher.

This episode sets the foundation for the entire Biostatistics Framework series, where each concept builds step-by-step into practical application.

If you’ve ever wondered why a specific statistical test was used in a paper—or whether it was the right one—this is where you start.

Topics Covered:

- Introduction to biostatistics in clinical research

- How to choose the correct statistical test

- Role of hypothesis in guiding analysis

- Study design and its impact on statistical decisions

- Understanding data types in research

- Independent vs related groups

- Internal validity and bias in clinical studies

- Sample vs population inference

- Null vs alternative hypothesis (conceptual review)

- Overview of the statistical decision framework

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#biostatistics #clinicalresearch #evidencebasedmedicine #epidemiology #DrBusti

Speaker: 

Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. 

Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. 

About This Channel: 

This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). 

Disclaimer: 

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Dyspnea should not be solely considered a diagnosis. It is a symptom that requires clinical reasoning. So the question becomes: what is driving the patient’s breathing discomfort? In this episode, Dr. Busti walks through the origin of the term, how it has been used historically, and how modern clinicians evaluate dyspnea across pulmonary, cardiac, and systemic causes.

We also connect the concept to real-world scenarios, including examples from Top Gun and The Hunger Games, to help illustrate how breathlessness presents in both physiologic and pathologic contexts.

If you’re a healthcare professional, student, or anyone looking to strengthen clinical thinking, this episode will help you understand not just what dyspnea means—but why it matters for patient care.

Subscribe to This Is Why with Dr. Busti for more content focused on understanding the “why” behind medical terminology and clinical decision-making.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

Chapter Table of Contents

*** ADD TIMESTAMP & CHAPTER TITLES HERE ****

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#dyspnea #shortnessofbreath #clinicalreasoning #medicalterminology #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This lecture is part of the This Is Why (TIW) evidence-based medicine series, helping clinicians connect study design to real-world decision-making.

Topics Covered:

- Internal validity vs external validity explained

- Independent vs dependent variables

- Causality in clinical research

- Threats to internal validity (history, maturation, testing, instrumentation)

- Statistical regression, selection, and mortality bias

- Threats to external validity (testing, selection, setting)

- Hawthorne effect and reactive behavior

- Multiple-treatment interference

- Applying evidence to patient care

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/internal-and-external-validity-research-design-methodology

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#internalvalidity #externalvalidity #biostatistics #studydesign #DrBusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This lecture is part of the This Is Why evidence-based medicine (EBM) series, designed to help clinicians connect research methodology to real-world practice.

Topics Covered:

- Equation of error: truth, bias, and random error

- Internal validity and critical appraisal

- Selection bias and sampling bias

- Confounding and lead-time bias

- Recall bias and observer bias

- Loss to follow-up and procedure bias

- Differential vs non-differential misclassification

- Study design hierarchy and risk of bias

- Publication bias and clinical trial registries

- Why bias control changes effect size

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-bias-clinical-research-design-methodology

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#bias in research #study design #internal validity #evidence based medicine #Dr Busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This case highlights how pharmacokinetics directly influences patient outcomes and why recognizing metabolism patterns is essential for safe prescribing.

Topics Covered:

- Benzodiazepine metabolism overview

- Phase 1 vs Phase 2 hepatic drug metabolism

- CYP450 oxidation and active metabolites

- Glucuronidation and drug clearance

- Pharmacokinetics in older adults

- Drug accumulation and prolonged effects

- Clinical decision-making in anxiolytic therapy

- High-yield pharmacology concepts for board preparation

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#benzodiazepinemetabolism #LOTdrugs #practicequestion #cyp450pharmacology #DrBusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Understanding study design is essential for interpreting medical literature and assessing the internal and external validity of results, thereby informing the application of the information in clinical practice. Different designs—such as randomized controlled trials, cohort studies, case-control studies, and cross-sectional analyses—each have specific strengths, limitations, and risks of bias that influence how results should be applied in clinical practice.

This lecture explains how study design fits into the broader clinical research process described by the NIH and how clinicians should evaluate studies when reading the medical literature.

As part of the This Is Why (TIW) evidence-based medicine (EBM) series, this lecture focuses on the reasoning behind clinical evidence so clinicians can understand why certain study designs carry more evidentiary weight than others.

Topics Covered:

- Study design in clinical research

- Descriptive vs analytic studies

- Observational vs experimental research

- Case-control studies

- Cohort studies

- Cross-sectional studies

- Randomized controlled trials (RCTs)

- Randomized crossover trials

- Explanatory vs pragmatic clinical trials

- Qualitative vs quantitative research

- Study design hierarchy and risk of bias

- Internal vs external validity

- Confounders and bias in clinical trials

- Clinical trial registration

- CONSORT reporting guidelines

This lecture is part of the This Is Why (TIW) evidence-based medicine (EBM) learning series with Dr. Busti. The series teaches clinicians how clinical studies are designed, how statistical results should be interpreted, and how research findings translate into real patient care decisions.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-of-study-designs-clinical-research-methodology-explained-ultimate-guide

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#StudyDesign #ClinicalResearch #EvidenceBasedMedicine #Biostatistics #Dr Busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

• Mechanism of action: muscarinic (M3) blockade → decreased bronchoconstriction
• Key drug: ipratropium (Atrovent)
• Common combinations: ipratropium/albuterol (DuoNeb, Combivent)
• Clinical uses: COPD maintenance/symptom relief, COPD exacerbation support, select asthma situations (often as add-on therapy in acute care)
• Routes & devices: MDI vs nebulized treatments, dosing frequency, and practical inhaler/neb pearls
• Adverse effects & warnings: dry mouth, cough, urinary retention (BPH), blurry vision/precipitating angle-closure symptoms if sprayed into eyes, and other anticholinergic considerations
• High-yield comparisons: SAMA vs LAMA (where tiotropium and other long-acting agents fit)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sama-short-acting-muscarinic-antagonist-ipratropium-bronchodilator

Get more with a free membership at https://www.thisiswhy.health/

• Access free downloads from our videos 
• Access deep dive content from Dr. Busti
• Organize content via playlists & collections
• Join live Q&A
• Receive member newsletters
• Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

• What LAMA / antimuscarinic bronchodilators are and how they work
• Where LAMA inhalers fit in COPD therapy and long-term symptom control
• Key differences and practical pearls for common COPD inhalers
• High-yield side effects, contraindications, and patient counseling points
• How to recognize and avoid common med errors and confusion with inhaler names/classes

Drugs covered:

• Tiotropium (Spiriva)
• Umeclidinium (Incruse Ellipta)
• Aclidinium (Tudorza Pressair)
• Glycopyrrolate (COPD maintenance formulations)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/lama-bronchodilators-copd-tiopotropium-umeclidinium-pharmacology

Get more with a free membership at https://www.thisiswhy.health/

• Access free downloads from our videos 
• Access deep dive content from Dr. Busti
• Organize content via playlists & collections
• Join live Q&A
• Receive member newsletters
• Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- What SABAs are and when they’re used (rescue vs controller)

- Beta-2 agonist mechanism of action (bronchodilation and smooth muscle effects)

- How fast albuterol works, typical duration, and why it’s “short-acting”

- Core therapeutic uses in asthma and COPD

- How SABAs fit into treatment plans (including “as needed” use)

- Common adverse effects: tachycardia, tremor, palpitations, and more

- Key patient counseling: inhaler technique and when to seek urgent care

Drugs discussed:

- Albuterol (rescue inhaler; MDI and nebulizer)

- Levalbuterol (alternative SABA)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/saba-short-acting-beta-agonists-albuterol-rescue-inhaler-asthma-copd

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#SABA #albuterol #asthma #COPD #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)

- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)

- Onset/duration differences and practical inhaler considerations

- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts

- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)

LABA drugs discussed for SEO/review:

- Salmeterol

- Formoterol

- Vilanterol

- Olodaterol

- Indacaterol

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/laba-long-acting-beta-agonists-asthma-copd-bronchodilators-pharmacology

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy

- Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization

- Expected impact on A1C reduction and how long these drugs take to show benefit

- Practical comparisons: pioglitazone vs rosiglitazone

Side effects & safety (high yield)

- Weight gain and edema / fluid retention

- Heart failure risk (when to avoid TZDs)

- Fracture risk with TZDs

Drugs covered for SEO / review

- Pioglitazone (primary focus)

- Thiazolidinediones / TZDs (drug class)

- Rosiglitazone (comparison)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tzd-thiazolidinediones-pioglitazone-type-2-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#pioglitazone #thiazolidinediones #tzd #type2diabetes #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Mechanism of action: how sulfonylureas increase insulin release

- Clinical use: where sulfonylureas still fit in modern Type 2 diabetes management

- Drug comparisons: key differences between glyburide, glipizide, and glimepiride

- Adverse effects: why hypoglycemia risk matters, plus weight gain and common pitfalls

- Safety & patient selection: older adults, renal impairment, missed meals, and other high-risk scenarios

Key drugs covered:

- Glipizide

- Glyburide 

- Glimepiride

- (Plus core concepts of oral hypoglycemics, insulin secretagogues, and antidiabetic drugs)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sulfonylureas-glipizide-glyburide-type-2-diabetes-pharmacology

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#sulfonylureas #type2diabetes #glipizide #glyburide #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Mechanism of action (MOA): how SGLT2 blockade drives glucosuria, modest A1c reduction, weight loss, and BP lowering

- Clinical use: where SGLT2 inhibitors fit for type 2 diabetes, plus major outcomes in heart failure and chronic kidney disease (CKD) (cardiorenal protection is a key reason they’re prioritized in modern guidelines)

- Key drugs (for exams + real-world practice): Empagliflozin (Jardiance), Dapagliflozin (Farxiga), Canagliflozin (Invokana), Ertugliflozin (Steglatro), and Bexagliflozin (Brenzavvy)

- Adverse effects & safety pearls: genital mycotic infections, volume depletion/hypotension, AKI considerations, and the “don’t-miss” rare events like euglycemic DKA (plus how to recognize it)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sglt2-inhibitors-canagliflozin-dapagliflozin-empagliflozin-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#sglt2inhibitors #empagliflozin #type2diabetes #diabetespharmacology #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Meglitinides overview: where they fit in type 2 diabetes (T2DM) therapy

- Drug names you must know: repaglinide and nateglinide

- Mechanism of action: how these insulin secretagogues stimulate insulin release (the KATP channel connection)

- Onset/duration & dosing concept: why they’re considered short-acting / prandial glucose agents

- Therapeutic application: targeting postprandial hyperglycemia and when they may (or may not) be chosen

- Adverse effects & safety: hypoglycemia, weight considerations, and key patient counseling points

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/meglitinides-repaglinide-nateglinide-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#meglitinides #repaglinide #nateglinide #type2diabetes #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- How to identify rapid-, short-, intermediate-, and long-acting insulin for Diabetes

- The difference between basal insulin vs bolus (mealtime) insulin

- How basal–bolus regimens work (plus common pitfalls)

- Practical tips for insulin administration, timing with meals, and avoiding errors

- High-yield clinical points you’re likely to see in courses and on exams

Insulins covered (for memorization + exam success):

- Rapid-acting: insulin lispro, aspart, glulisine

- Short-acting: regular insulin

- Intermediate-acting: NPH insulin

- Long-acting / basal: insulin glargine, detemir, degludec

- Premixed options: 70/30 mixes (NPH/regular and related premixed products)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/insulin-types-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#insulin #diabetes #insulintypes #diabetespharmacology #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Mechanism of action: incretin mimetic effects (GLP-1) and what that means for glucose control

- Therapeutic use: where GLP-1 agonists fit in type 2 diabetes (T2DM) treatment strategies

- Key agents: semaglutide, plus comparisons to liraglutide, dulaglutide, and exenatide

- Benefits & counseling pearls: weight effects, dosing basics, and practical patient education

- Adverse effects & precautions: the high-yield safety points clinicians get tested on (and seen in clinical practice)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/glp-1-receptor-agonists-semaglutide-dulaglutide-liraglutide-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#glp1receptoragonist #semaglutide #type2diabetes #diabetesmedications #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#pramlintide #amylinanalog #diabetespharmacology #type1diabetes #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

• MOA: How HMG-CoA reductase inhibitors reduce hepatic cholesterol synthesis and increase LDL clearance
• Clinical uses: Hyperlipidemia treatment, primary prevention, and secondary prevention for ASCVD
• High-yield statins: Atorvastatin, rosuvastatin, simvastatin, pravastatin (and how to think about intensity)
• Adverse effects: Statin myopathy, muscle pain/weakness, and rare rhabdomyolysis
• Key interactions: CYP3A4 interactions (especially with certain statins) and what to watch for clinically
• Pearls for exams: How to connect lipid lowering drugs to patient cases and test questions

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/statins-hmg-coa-reductase-inhibitors-ldl-lowering

Get more with a free membership at https://www.thisiswhy.health/

• Access free downloads from our videos 
• Access deep dive content from Dr. Busti
• Organize content via playlists & collections
• Join live Q&A
• Receive member newsletters
• Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#statins #hmgcoareductaseinhibitors #ldllowering #lipidloweringdrugs #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

• What omega-3 fatty acids (EPA & DHA) are and how they work
• Fish oil (EPA vs DHA): what matters clinically (and what doesn’t)
• How omega-3s affect triglycerides and hypertriglyceridemia
• Icosapent ethyl vs “fish oil”: dosing, indications, and counseling

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/omega-3-fatty-acids-epa-vs-dha-fish-oil-icosapent-ethyl

Get more with a free membership at https://www.thisiswhy.health/

• Access free downloads from our videos 
• Access deep dive content from Dr. Busti
• Organize content via playlists & collections
• Join live Q&A
• Receive member newsletters
• Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#omega3fattyacids #fishoil #icosapentethyl #EPADHA #busti

Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Key topics include:

- Normal clotting factor synthesis & activation

- Role of vitamin K and the coagulation cascade

- Thrombin's multiple functions in clot formation, stabilization, and fibrinolysis

- Clinical relevance: What happens when the balance is disrupted?

Whether you're studying or simply want to understand the "why" behind anticoagulation and hemostasis management, this physiology review makes complex concepts easy and applicable.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/coagulation-cascade-thrombosis-physiology-made-easy

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#CoagulationCascade #Hemostasis #BloodClottingCascade #PhysiologyMadeEasy #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- How platelet adhesion starts (the role of von Willebrand factor (vWF) and GPIb)

- How platelet activation amplifies the response (ADP and thromboxane A2 / TXA2)

- How platelet aggregation occurs (GPIIb/IIIa binding fibrinogen)

- The key endogenous “brakes” that limit clot growth (nitric oxide and prostacyclin / PGI2)

- How clinicians think about platelet function testing and antiplatelet drugs in practice

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/platelet-aggregation-thrombosis-clinical-essentials

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#PlateletAggregation #Thrombosis #Hemostasis #PlateletPhysiology #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- The GPIIb/IIIa receptor and how blocking it reduces platelet activation

- Where GPIIb/IIIa inhibitors fit in clinical practice

- High-yield uses: acute coronary syndrome (ACS) and PCI/stents

- Major adverse effects (including bleeding) and top safety pearls

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/gpiibiiia-inhibitors-tirofiban-eptifibatide-antiplatelet-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#gpiibiiiainhibitors #tirofiban #antiplateletpharmacology #eptifibatide #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- The P2Y12 (ADP) receptor and how blocking it reduces platelet activation

- Where P2Y12 inhibitors fit in dual antiplatelet therapy (DAPT)

- High-yield uses: acute coronary syndrome (ACS), PCI/stents, and secondary prevention

- Major adverse effects (including bleeding) and top safety pearls

- The exam-favorite comparisons: prodrug activation, onset/offset, reversibility, and IV vs PO options

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/p2y12-adp-inhibitors-antiplatelet-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#p2y12inhibitors #clopidogrel #antiplateletpharmacology #ticagrelor #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

What you’ll learn:

- How to approach CAP pneumonia like a clinician: presentation, diagnosis, and key differentials

- How to assess severity using CURB-65 and the Pneumonia Severity Index (PSI score)

- How to decide outpatient pneumonia vs inpatient pneumonia management

- How to choose CAP antibiotics with guideline-based empiric antibiotics pneumonia selection

- What “atypical coverage” means (and when you need it)

- Common pitfalls (including aspiration pneumonia vs CAP) and how to avoid them

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/community-acquired-pneumonia-cap-treatment-guidelines

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#CommunityAcquiredPneumonia #CAP #PneumoniaTreatment #PneumoniaGuidelines #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will , Dr. Busti breaks down atrial fibrillation in a clear, practical way so you can confidently answer:

- What is AFib and why does it matter clinically?

- How do you identify AFib on an ECG/EKG (classic “irregularly irregular” rhythm)?

- When is it atrial fibrillation with RVR and what do you do first?

- Rate control vs rhythm control: how to think about each strategy

- Stroke risk: using CHA2DS2-VASc (and bleeding risk with HAS-BLED)

- Anticoagulation in AFib: DOACs vs warfarin (high-yield clinical pearls)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/atrial-fibrillation-afib-review-made-easy

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#AtrialFibrillation #AFib #afibmanagement atrialfibrillationrvr #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

You’ll learn how to:

- Identify what makes a drug a “sulfonamide”

- Distinguish antimicrobial vs non-antimicrobial sulfonamides

- Understand the structural features linked to higher allergy risk (why Bactrim is different)

- Apply practical guidance for patients with a reported sulfa allergy

- Avoid unnecessary “all-or-nothing” medication exclusions while still prioritizing safety

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/topics/sulfa-allergy-drugs-to-avoid

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#SulfaAllergy #SulfonamideAllergy #Bactrim #SulfaCrossReactivity #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this video you’ll learn:

- What odynophagia means and how to say it

- How it differs from dysphagia

- Common causes of pain when swallowing (throat vs esophageal causes)

- High-yield differentials like esophagitis, GERD, and pill-induced esophagitis

- Why immunocompromised patients with odynophagia may need a different workup

Watch next in the Medical Dictionary series and build your terminology foundation for clinical practice and exams.

The goal = make medical education easy and clinically relevant.

👉 Access this episode at the website: https://www.thisiswhy.health/topics/odynophagia-painful-swallowing-medical-term-definition

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Odynophagia #PainfulSwallowing #SwallowingPain #medicaldictionary #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

What you’ll learn (quick + practical):

- Dysphagia definition and how it shows up in real patients (“trouble swallowing)

- Oropharyngeal vs esophageal dysphagia: symptom patterns that matter

- Common causes: stroke dysphagia, Parkinson disease, dementia, neurologic/neuromuscular conditions, GERD, strictures/rings, eosinophilic esophagitis, and achalasia

- Complications: aspiration, aspiration pneumonia, dehydration, malnutrition, food impaction

- Evaluation basics: bedside swallow assessment, swallow evaluation, modified barium swallow / VFSS, FEES, barium swallow, and upper endoscopy (EGD)

The goal = make medical education easy and clinically relevant.

👉 Access this episode at the website: https://www.thisiswhy.health/topics/dysphagia-difficulty-swallowing-medical-term-definition

👉 Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Dysphagia #DifficultySwallowing #Dysphagiacauses #medicaldictionary #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

We compare the core agents—citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline—covering indications, mechanism, and clinical nuances that matter at the bedside. You’ll learn how dose, half-life, metabolism, and side-effect patterns influence patient-specific choices, and what to monitor for safety and success.

This episode includes practical guidance on:

• Managing sexual dysfunction, QT risk, and SIADH
• Recognizing CYP2D6 interactions
• Understanding fluoxetine’s long half-life
• Applying MAOI washout rules to avoid serotonin syndrome
• Starting low and titrating slow for anxiety

If you want to go beyond memorization and understand the why behind the what, this episode connects the science, safety, and strategy of SSRI use.

🔹 Download study tables, mechanisms, and comparison charts for this video at https://www.thisiswhy.health/topics/pharmacology-review-ssri-antidepressants

Disclaimer:
This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

What you’ll learn

• Quality first: use RIPE to confirm a film is worth interpreting
• A structured read with A-B-C-D-E-F-G-H-I
• How projection changes appearance (AP vs PA vs lateral)
• Reliable checks for effusions, pneumothorax, edema, and device/artifact confounders
• How to synthesize a clear impression clinicians can act on

Show notes and downloads: https://www.thisiswhy.health/topics/chest-xray-how-to-read-step-by-step-guide

Get more (free) at ThisIsWhy.health
Access the video, free downloads (mnemonic tables), organize content via playlists & collections, join live Q&A, receive member newsletters, and unlock partner discounts—resources built to help clinicians move from what to why and improve real-world decisions.

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Build confidence in your exam readiness and clinical mastery with free resources at https://thisiswhy.health

Disclaimer:
This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode of This Is Why, Dr. Busti reviews national BPS pass rate trends and explores what separates first-time test takers who succeed from those who don’t. Using data from multiple specialties, he highlights how residency training, study strategy, and preparation methods predict success — and why relying solely on memorization or guesswork fails so many candidates.

You’ll learn how to interpret your own readiness, avoid common traps like overemphasizing blueprints or anecdotal advice, and design a structured, question-based study plan that mirrors the way you’ll be tested. Whether you’re pursuing BCPS, BCCCP, BCACP, or another BPS certification, this episode will equip you with the insights and mindset needed to succeed on the first try.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode of This Is Why, Dr. Busti breaks down how BPS exams are built, what “testable” really means, and why focusing on validated, evidence-based concepts gives you a major advantage. Drawing on decades of experience as a pharmacist, educator, and exam review developer, he explains the multi-step process used to create fair, reliable, and job-related BPS exams.

Listeners will learn why not all new or clinically relevant content appears on the test, how to interpret the exam blueprint effectively, and which study approaches are proven to help first-time takers pass. Dr. Busti also explains why question banks and application-based practice are essential for success — and how understanding the “why” behind each concept improves long-term retention.

If you’re preparing for a BPS specialty exam or mentoring someone who is, this episode offers practical, motivating insights to help you study smarter and perform with confidence.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode of This Is Why, Dr. Busti unpacks the key predictors of NAPLEX performance based on data and published literature. You’ll learn how GPA, pre-admission metrics, clinical performance, study effort, and test timing correlate with first-time pass rates — and how to interpret these factors to improve your own odds.

Drawing from decades of experience teaching pharmacy and preparing students for licensing exams, Dr. Busti helps listeners identify what’s within their control and how to act on it. From taking practice exams early to focusing on question-based learning and targeted remediation, this episode offers a structured framework for building a smarter, evidence-based study plan.

If you’re getting ready for the NAPLEX or mentoring students who are, this conversation provides both data-driven insight and actionable strategy for success on the first attempt.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode of This Is Why, Dr. Busti breaks down the data behind NAPLEX performance trends, exploring factors such as the rapid growth of pharmacy schools, shifts in applicant pools, and the impact of the COVID-19 pandemic on learning and assessment.

Drawing from decades of experience as a pharmacist, physician, and nurse, Dr. Busti helps listeners understand how these changes have shaped the profession — and what students can do to overcome them. You’ll learn how to adapt your mindset, refine your study strategy, and focus on high-yield, testable material rather than memorizing everything in a textbook.

If you’re feeling discouraged by national pass rate trends, this episode offers both context and encouragement — showing you how to take control of your preparation, regain confidence, and move toward NAPLEX success.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode of This Is Why, Dr. Busti explains how the NAPLEX is built by the NABP, why understanding its blueprint helps you focus your studying, and how to avoid wasting time on untested or emerging content. Drawing on his own experience as a pharmacist, physician, and nurse — and decades teaching pharmacy students — he reveals the process behind question validation, exam updates, and psychometric testing.

Listeners will learn how to identify high-yield, testable concepts that align with national standards of care, use question banks effectively, and balance their preparation between memorization and mastery. Dr. Busti’s practical insights will help you create a focused, efficient study plan designed for success on the first attempt.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Dr. Busti also unpacks the rationale behind antibiotic selection, comparing macrolide monotherapy, beta-lactam combinations, and fluoroquinolone alternatives — all while reinforcing how understanding why each answer choice is correct or incorrect leads to long-term mastery.

If you’re preparing for your boards, rotations, or want to strengthen your diagnostic thinking, this episode helps you move beyond memorization into true clinical understanding.

Access bonus materials and downloads https://www.thisiswhy.health/topics/practice-test-question-pneumonia-treatment

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Find resources for this topic at https://www.thisiswhy.health/topics/pharmacology-review-tca-tricyclic-antidepressants

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

In this episode, you’ll learn:
- How SNRIs work in the brain and differ from SSRIs, TCAs, and MAOIs
- Key medications: venlafaxine, desvenlafaxine, duloxetine, milnacipran, levomilnacipran
- Important side effects, including blood pressure changes and SIADH in older adults
- Tips for safe switching, monitoring, and counseling patients

Companion tables (indications, mechanisms, PK/PD, side-effect grid, and monitoring prompts) are available for download and teaching at https://www.thisiswhy.health/topics/pharmacology-review-snri-antidepressants

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

• Why MAOIs remain relevant for treatment-resistant depression
• How irreversible MAO-A/B inhibition elevates serotonin, norepinephrine, and dopamine
• Practical washout rules (why 14 days after MAOI, generally 7 days before starting an MAOI; longer with fluoxetine)
• High-yield differences (e.g., selegiline transdermal for depression vs. oral formulations for Parkinson’s disease)
• Key drug–drug risks (serotonergic agents, certain opioids like tramadol, linezolid/methylene blue)
• Tyramine-containing foods and counseling to prevent hypertensive crisis

Whether you’re prepping for boards or refining clinical practice, this walkthrough turns “what” into the why behind safer, smarter antidepressant selection.

Download the companion tables (indications, interactions, tyramine foods, counseling checklists) to keep handy for boards, precepting, and bedside teaching at https://www.thisiswhy.health/topics/pharmacology-review-maoi-monoamine-oxidase-inhibitors-antidepressants

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access tables, visuals, and playlists for this video at https://www.thisiswhy.health/topics/pharmacology-review-proton-pump-inhibitors-ppi

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

You’ll learn how P-CABs compare to H₂ receptor antagonists and proton pump inhibitors (PPIs) in terms of mechanism, onset, and duration of acid control. Dr. Busti explains the unique pharmacodynamic and pharmacokinetic properties that make vonoprazan a valuable alternative for patients who do not adequately respond to PPIs.

The discussion connects the drug’s molecular action at the parietal cell to the anatomy of the gastrointestinal tract, helping you understand why this mechanism matters in conditions such as GERD, H. pylori infection, peptic ulcer disease, and erosive esophagitis. You’ll also explore the potential side effects, electrolyte disturbances, and drug–drug interactions to watch for in clinical practice.

By grounding pharmacology in pathophysiology and anatomy, this episode helps clinicians and trainees alike integrate new therapies into patient care with confidence and context.

Access tables for this episode at https://www.thisiswhy.health/topics/pharmacology-review-potassium-competitive-acid-blockers-pcab

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access downloads for this episode at https://www.thisiswhy.health/topics/pharmacology-review-inhaled-corticosteroids-asthma-copd

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

• Choosing the right MRA for HF, resistant HTN, CKD/T2D, primary hyperaldosteronism, and ascites
• Why selectivity and structure (steroidal vs non-steroidal) matter for efficacy and side effects
• Practical monitoring: potassium, renal function, blood pressure, and patient education

Access bonus materials and downloads from the episode at https://www.thisiswhy.health/topics/pharmacology-review-loop-diuretics

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

• Choosing the right MRA for HF, resistant HTN, CKD/T2D, primary hyperaldosteronism, and ascites
• Why selectivity and structure (steroidal vs non-steroidal) matter for efficacy and side effects
• Practical monitoring: potassium, renal function, blood pressure, and patient education

Access bonus materials and downloads at https://thisiswhy.health

Disclaimer: This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.

He discusses the common gap in medical training: being taught what to do and how to do it, but not always why. Through his own journey — from the ICU and emergency department to academic medicine and beyond — Dr. Busti explains how understanding the “why” transforms clinical decision-making, patient outcomes, and professional confidence.

Listeners will gain insight into Dr. Busti’s background, his passion for connecting the dots in medicine, and his vision for helping healthcare professionals move beyond rote practice to true mastery. This Is Why invites you to go deeper — to understand not just what you do, but why it matters, and how that understanding can transform the way you care for patients.